Effects of Polyphenols of Pomegranate Fruit Peel Extract on Inflammation and Oxidative Stress in Metabolic Syndrome
NCT05915117 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2023-06-22
Summary
The purpose of this study is to evaluate the effects of polyphenols of pomegranate fruit peel extract compared to placebo on oxidative stress and inflammation in overweight and obese subjects with metabolic syndrome.
Conditions
- Metabolic Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
Polyphenols of pomegranate fruit peel extract (PoPex)
PoPex in form of capsule will be orally administered in total daily dose of 500/mg in subjects with metabolic syndrome and obesity over 8 weeks.
- DRUG
-
Placebo in form of capsule will be orally administered in subjects with metabolic syndrome and obesity over 8 weeks.
Sponsors & Collaborators
-
University of Banja Luka
lead OTHER
Principal Investigators
-
Ranko Škrbić, Professor · University of Banja Luka
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-04-01
- Primary Completion
- 2023-12-20
- Completion
- 2024-08-20
Countries
- Bosnia and Herzegovina
Study Locations
More Related Trials
-
A 3-part Study to Evaluate Safety, Tolerability, Food Effect and Drug-drug Interactions of RXC007 in Healthy Volunteers
NCT04931147 ·Status: COMPLETED ·Phase: PHASE1
-
PK And Safety Study Of PF-04171327 In Healthy Japanese And Western Subjects In Fasting And Fed Conditions
NCT01362673 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial of Crocus Kozanis Administration in Obese Children and Adolescents
NCT05572749 ·Status: COMPLETED ·Phase: NA
-
Influence of Plantago Major on Mineral Metabolism and Selected Biochemical Parameters in Obese Women
NCT03439540 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn About Study Medicine Called PF-07261271 in Healthy People
NCT05536440 ·Status: COMPLETED ·Phase: PHASE1
-
Effect Of Single-Dose PF-05175157 On Metabolic And Cardiopulmonary Parameters
NCT01819922 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Of PF-04620110 As A Modified-Release Formulation In Healthy Overweight Or Obese Subjects
NCT01474941 ·Status: COMPLETED ·Phase: PHASE1
-
Study To Evaluate Safety, Tolerability, And Pharmacokinetics Of PF-06473871 In Normal Healthy Adults
NCT01753791 ·Status: COMPLETED ·Phase: PHASE1
-
A Drug-Drug Interaction Study Between PF-06882961 and PF-06865571 in Healthy Adult Participants and Overweight Adults or Adults With Obesity Who Are Otherwise Healthy
NCT04839393 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991)
NCT01953731 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Assess The Safety, Tolerability, And Pharmacokinetics (PK) Of Multiple Doses Of PF-06865571 In Healthy, Including Overweight And Obese, Adult Subjects
NCT03230383 ·Status: COMPLETED ·Phase: PHASE1
-
Non-Comparative Study to Assess the Efficacy and Safety of the New Food Supplement FaseMETS
NCT02912325 ·Status: COMPLETED ·Phase: NA
-
A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BMS-986263 in Healthy Participants
NCT03142165 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Effect of Tablet Formulation and Food on PF-07104091 in Healthy Participants
NCT05431153 ·Status: COMPLETED ·Phase: PHASE1
-
Effect Of Modafinil And Pioglitazone On The Pharmacokinetics Of Palbociclib (PD-0332991)
NCT02222441 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases
NCT03163771 ·Status: COMPLETED
-
Bioavailability of SPMs in Obese Humans
NCT04701138 ·Status: COMPLETED ·Phase: NA
-
Trial to Determine the Immunomodulatory Activity of PTM-001 in Patients With Hidradenitis Suppurativa
NCT05020730 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study To Evaluate the Safety, Tolerability, And Pharmacokinetics Of PF-06266047 In Healthy Adult Subjects
NCT02539550 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of TAK-279 in Healthy Chinese Adults
NCT06111547 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of GFH312 in Healthy Subjects
NCT04676711 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing PF-06273340 Immediate Release Tablet, PF-06273340 Modified Release Tablets To PF-06273340 Oral Solution In The Fasted State. This Study Will Also Compare PF-06273340 Modified Release Tablets In Fasted And Fed State
NCT01706796 ·Status: COMPLETED ·Phase: PHASE1
-
A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed State
NCT01563497 ·Status: COMPLETED ·Phase: PHASE1
-
Phyllantus Amarus for the Protection of Liver Health
NCT03349697 ·Status: COMPLETED ·Phase: PHASE2
-
A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649
NCT02151617 ·Status: COMPLETED ·Phase: PHASE1